Respiratory stimulation

Respiratory stimulation is an acute increase in the rate, depth, or conscious awareness of breathing produced by a psychoactive substance.

As a drug effect it is dose-proportional and transient, easing as the substance wears off; this distinguishes it from clinical hyperventilation syndromes, which persist independently. It ranges from a mild quickening that goes nearly unnoticed to a pronounced, effortful increase in respiratory drive that demands attention.

Respiratory stimulation is a common interoceptive effect across several drug classes. It is most commonly induced at moderate to high doses under stimulants such as amphetamine, MDMA, and cocaine, and under antidepressants such as mirtazapine and tianeptine. It also appears under deliriants such as datura and, less predictably, under cannabinoids such as cannabis.

Respiratory stimulation is felt as a persistent urge to breathe more — faster, deeper, or both — even when the body's oxygen needs do not demand it. The chest feels active and slightly pressured; breath sits higher in the lungs, and each inhalation draws conscious attention.

It commonly comes with mild chest warmth, a faint lightheadedness if breathing outpaces metabolic demand, and a rising awareness of the heartbeat. Attending to the breath tends to amplify it. At higher doses, particularly under stimulants, the effect becomes labored and harder to dismiss.

Respiratory stimulation arises through different pathways depending on the drug class:

• Stimulants — activate central respiratory centers and the sympathetic nervous system, raising both breathing rate and tidal depth.
• Antidepressants — modulate serotonergic and noradrenergic pathways in the brainstem, where respiratory drive is regulated, producing stimulation across a range of doses.
• Deliriants — anticholinergic disruption of autonomic balance can produce effortful, irregular breathing as part of broader autonomic arousal.
• Cannabinoids — act on CB1 receptors; respiratory effects are less consistent than those of the other classes.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses raise both likelihood and intensity across all implicated classes. Physical exertion during a session amplifies it further; a calm, sedentary setting tends to moderate it. People with pre-existing respiratory conditions may notice it earlier and find it more uncomfortable.

Expectation plays a modest role — those already attentive to bodily sensation are more likely to track and report it. Tolerance to the effect develops with sustained stimulant use.